1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million. » Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read More
Alert: 48% Upside on Under-the-Radar Tech Stock
Investment Alert: Buy Climb Global Solutions (CLMB) Under $50/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Read More
Alert: 26.7% Upside In Rising Cybersecurity Star
Investment Alert: Buy SentinelOne (S) Under $16/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Read More
Market Commentary: Is Buffett’s IPO Bet In A Bubble?
It’s rare that the Oracle of Omaha makes a bet on a tech company, let alone one that has recently had an initial public offering. It’s even rarer for him to invest pre-IPO, but that’s exactly what he did with Snowflake.
Read More
Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away,
» Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read MoreThe Ivy
Buffett’s Bet on Booze, Why He’s Doubling Down
Warren Buffett has never been one to chase fads. While he’s adapted over time, buying Apple and even dabbling in tech disruptors like Snowflake, his compass still points due value.
At its heart, value investing comes down to a deceptively simple idea, buy businesses trading below what they’re really worth. But pulling that off consistently?
» Read more about: Buffett’s Bet on Booze, Why He’s Doubling Down »
Read MoreThe Spotlight
Is Apple’s Dip The Perfect Buying Opportunity?
Apple has fallen by almost 15% from nearly $200 per share in recent months. The decline appeared to precede the major market averages more recent correction but does it bode ominously for Apple or has the recent pullback offered new buyers an opportunity to get in on a great company at sale prices?
In the near-term,
» Read more about: Is Apple’s Dip The Perfect Buying Opportunity? »
Read MoreThe Daily
Illinois soybean farmers struggle with unpredictable trade war and rising costs
Farmers say they face added pressure from South American countries, which have become increasingly competitive as China turns to these markets.
Offer valid for non-subscribers only
» Read more about: Illinois soybean farmers struggle with unpredictable trade war and rising costs »